Last reviewed: June 12, 2026
Last updated: June 12, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Midwest residents struggling with weight management now have access to compounded GLP-1 receptor agonists through PlexusDx telehealth services, which serve all 50 states including Illinois, Ohio, Michigan, and Indiana. Clinical data shows GLP-1 medications reduce body weight by 15-22% over 68 weeks when combined with lifestyle modification. PlexusDx pairs prescription medications with genetic insights to create individualized treatment protocols for each patient.
How GLP-1 Telehealth Works Across Midwest States
PlexusDx operates a fully remote telehealth model that eliminates geographic barriers for Midwest patients in Illinois, Ohio, Michigan, and Indiana. Licensed healthcare providers conduct initial consultations entirely online, review medical history and weight management goals, and determine candidacy for GLP-1 therapy without requiring office visits. Once approved, prescriptions are filled through licensed 503A compounding pharmacies and shipped directly to each patient's address within 3-5 business days.
The telehealth approach removes common obstacles that Midwest residents face with traditional weight loss clinics, including limited availability in rural areas and time constraints from work or family responsibilities. PlexusDx accepts HSA and FSA funds for treatment, making GLP-1 therapy financially accessible across income levels. No membership fees, insurance requirements, or ongoing subscription commitments exist—patients pay only for the medications they use and genetic testing if chosen.
Compounded Semaglutide Pricing and Access in the Midwest
Compounded semaglutide injections through PlexusDx start at $149 per month, representing one of the most affordable GLP-1 options for uninsured Midwest patients in Illinois, Ohio, Michigan, and Indiana. All compounded medications originate from licensed 503A compounding pharmacies that meet strict quality and safety standards regulated by state boards of pharmacy. Your dose may need to go up. Your price won't.—PlexusDx maintains flat monthly pricing regardless of which strength your provider prescribes as you progress through treatment.
Semaglutide works by activating GLP-1 receptors in the brain that regulate hunger hormones and appetite control, leading to reduced calorie intake and sustainable weight loss. Most patients begin with a low dose and gradually increase over 4-5 weeks to minimize gastrointestinal side effects while allowing the body to adapt. PlexusDx offers both injection and oral semaglutide formulations so Midwest patients can select the delivery method that fits their lifestyle and preferences.
Genetic Testing for Personalized GLP-1 Response in the Midwest
PlexusDx offers the Precision Peptide Genetic Test as an optional add-on ($99 after the first month of treatment) that analyzes peptide-pathway genetic variants to predict individual medication response. The test evaluates key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—genes that directly influence how your body responds to GLP-1 agonists. By mapping 14 peptide pathways and 150+ genetic insights, the test helps Midwest providers optimize medication selection and dosing for superior outcomes.
Illinois, Ohio, Michigan, and Indiana patients who complete genetic testing receive detailed reports explaining their unique peptide-pathway predispositions and how these influence appetite regulation, metabolic rate, and medication efficacy. This personalized approach reduces trial-and-error medication adjustments and accelerates the timeline to effective weight loss. PlexusDx uses genetic data solely to enhance treatment precision—the company does not share genetic information with third parties or use it for purposes beyond clinical optimization.
Tirzepatide and Dual Compound Options for Midwest Patients
Beyond semaglutide, PlexusDx provides compounded tirzepatide injections starting at $249 per month for Midwest residents in Illinois, Ohio, Michigan, and Indiana who seek dual GLP-1 and GIP receptor agonism. Tirzepatide activates both GLP-1 and GIP pathways simultaneously, producing greater appetite suppression and weight loss than single-pathway medications in clinical trials. PlexusDx also offers GLP-Squared Injection (combined semaglutide and tirzepatide) starting at $249 per month for patients seeking synergistic peptide effects.
Oral tirzepatide and oral GLP-Squared formulations serve patients who prefer tablet administration over weekly or twice-weekly injections. Oral tirzepatide costs $279 per month while oral GLP-Squared (dual compound) starts at $369 per month. All Midwest patients receive the same flat-rate pricing structure—your dose may increase as your provider adjusts your treatment plan, but your monthly cost remains constant throughout your therapy journey.
Why Midwest Patients Choose PlexusDx Over Traditional Weight Loss Clinics
Traditional weight loss centers in Illinois, Ohio, Michigan, and Indiana often require membership fees, in-person appointments, and reliance on health insurance—barriers that PlexusDx eliminates through its telehealth-first model. PlexusDx serves all 50 states with identical clinical standards and medication quality, ensuring Midwest patients receive the same precision-health approach as urban centers. Licensed healthcare providers spend time understanding each patient's medical history, lifestyle, and weight loss goals rather than rushing through appointments.
Midwest patients also benefit from PlexusDx's transparent, predictable pricing structure and HSA/FSA eligibility, which reduces out-of-pocket costs significantly compared to in-office GLP-1 programs. The combination of compounded medications, telehealth convenience, genetic testing options, and ongoing provider support creates a comprehensive weight loss solution tailored to individual needs. PlexusDx medications arrive at home ready to use, eliminating pharmacy delays and ensuring consistent medication availability for Midwest residents.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I get GLP-1 therapy in Illinois, Ohio, Michigan, or Indiana without leaving home?
Yes. PlexusDx conducts all consultations and follow-ups via secure telehealth, and medications are shipped directly to your address. Providers serve all 50 states, including the entire Midwest, with no geographic restrictions or in-person visit requirements.
What does compounded semaglutide from PlexusDx cost for Midwest patients?
Compounded semaglutide injections start at $149 per month with flat pricing across all dose levels. Your dose may need to go up. Your price won't. PlexusDx also accepts HSA and FSA funds to reduce your net cost further.
Is compounded GLP-1 from PlexusDx safe and regulated?
All PlexusDx medications come from licensed 503A compounding pharmacies regulated by state pharmacy boards. These facilities meet strict quality, sterility, and safety standards. Compounded medications are not FDA-approved, but they follow the same manufacturing protocols as FDA-approved injectable drugs.
How does the Precision Peptide Genetic Test improve my GLP-1 results?
The test analyzes peptide-pathway variants (GIPR, GLP1R, FTO, MC4R) that predict your individual response to GLP-1 and GIP medications. Results guide your provider in selecting the right compound and dose, reducing trial-and-error and accelerating weight loss. The test costs $99 and is available as an add-on after your first month of treatment.
What if I don't have health insurance? Can I still afford GLP-1 through PlexusDx?
Yes. PlexusDx serves uninsured patients without requiring insurance or membership fees. Semaglutide starts at $149/mo, and all medications are HSA/FSA-eligible. Many patients find compounded GLP-1 more affordable than commercial alternatives, even without insurance coverage.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Your Guide to Semaglutide Dosing: What’s the Highest Dose of Compounded Semaglutide?
Are Ozempic Side Effects Immediate? What You Need to Know